Athena Athena

X

List of USP Standards of MolPort-001-944-253 on PharmaCompass.com.

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

USP

Contact Supplier
    Flag U.S.A
    Digital Content Digital Content

    Ondansetron Resolution Mixture (50 mg)

    URL Supplier Web Content
    1478630
    N/A
    R041W0
    G0K261 (28-FEB-2017)
    730
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    USP

    Contact Supplier
      Flag U.S.A
      Digital Content Digital Content

      Ondansetron Related Compound D (30 mg) (9-Methyl-3-meth...

      URL Supplier Web Content
      1478629
      N/A
      R065P0
      H0I048 (31-AUG-2018)
      805
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      USP

      Contact Supplier
        Flag U.S.A
        Digital Content Digital Content

        Ondansetron Related Compound C (30 mg) (1,2,3,9-tetrahy...

        URL Supplier Web Content
        1478618
        27397-31-1
        R033L0
        H0K321 (31-MAR-2017)
        805
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        USP

        Contact Supplier
          Flag U.S.A
          Digital Content Digital Content

          Ondansetron (300 mg)

          URL Supplier Web Content
          1478571
          99614-02-5
          R054C0
          F0E281 (28-FEB-2018)
          305
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          left grey arrow
          right gray arrow
          • TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
          • TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
          • FILM;ORAL - 4MG
          • FILM;ORAL - 8MG
          Ask Us for Pharmaceutical Supplier and Partner
          Ask Us, Find A Supplier / Partner
          No Commissions, No Strings Attached, Get Connected for FREE

          What are you looking for?

          How can we help you?

          The request can't be empty

          Please read our Privacy Policy carefully

          You must agree to the privacy policy

          The name can't be empty
          The company can't be empty.
          The email can't be empty Please enter a valid email.
          The mobile can't be empty
          Post Enquiry
          POST ENQUIRY